Related Experiment Videos
Calcium antagonists as a new treatment modality in hypertension
1New York Hospital-Cornell Medical Center, New York, New York.
Insights
Human hypertension mechanisms vary. Calcium and magnesium metabolism abnormalities are linked to low-renin hypertension, suggesting targeted calcium antagonist therapies for specific patient groups.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Hypertension involves long-term vasoconstriction, potentially with diverse underlying mechanisms.
- The renin-angiotensin-aldosterone system's activation is a known factor in some hypertension cases.
- Emerging research suggests a role for calcium ions in low-renin essential hypertension.
Purpose of the Study:
- To investigate the role of calcium and magnesium metabolism in hypertension.
- To explore the effectiveness of calcium antagonist drugs in specific hypertensive patient subgroups.
- To support the concept of hypertension heterogeneity and personalized drug therapy.
Main Methods:
- Identifying specific abnormalities in calcium and magnesium metabolism.
- Correlating metabolic deviations with renin system activity.
- Evaluating antihypertensive therapy efficacy with calcium antagonists like nitrendipine.
Main Results:
- Specific calcium and magnesium metabolism abnormalities were identified in relation to renin system deviations.
- Calcium antagonist therapy (e.g., nitrendipine) showed effectiveness in patients with low renin activity and low serum ionized calcium.
- These findings highlight a potential link between mineral metabolism and hypertension subtypes.
Conclusions:
- Human hypertension is heterogeneous, with distinct pathophysiological mechanisms.
- Abnormalities in calcium and magnesium metabolism may characterize specific hypertension types.
- Targeted antihypertensive drug therapy, particularly calcium antagonists, shows promise for specific patient populations.
Abstract:
The long-term vasoconstriction which is characteristic of human hypertension may be mediated by entirely different mechanisms in various hypertensive patients. In some whose hypertension is related to activation of the renin-angiotensin-aldosterone control system, appropriate antirenin therapy is effective. Recent studies indicate that calcium ions may play a special role in the etiology of low-renin essential hypertension. Specific abnormalities in calcium and magnesium metabolism which are related to deviations in the renin system have been identified. Antihypertensive therapy with calcium antagonist drugs such as nitrendipine appears to be most effective in patients with low levels of renin activity and serum ionized calcium. These observations support the concept of the heterogeneity of human hypertension and could represent a significant step towards more specific antihypertensive drug therapy.